DK1761542T3 - Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidler - Google Patents
Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidlerInfo
- Publication number
- DK1761542T3 DK1761542T3 DK05754708T DK05754708T DK1761542T3 DK 1761542 T3 DK1761542 T3 DK 1761542T3 DK 05754708 T DK05754708 T DK 05754708T DK 05754708 T DK05754708 T DK 05754708T DK 1761542 T3 DK1761542 T3 DK 1761542T3
- Authority
- DK
- Denmark
- Prior art keywords
- octahydropyrrolo
- antiviral agents
- pyrrole derivatives
- pyrrole
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Communicable Diseases (AREA)
- Neurology (AREA)
- Transplantation (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US57875904P | 2004-06-09 | 2004-06-09 | |
PCT/EP2005/005895 WO2005121145A2 (en) | 2004-06-09 | 2005-06-01 | Octahydro-pyrrolo[3,4-c] derivatives and their use as antiviral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1761542T3 true DK1761542T3 (da) | 2008-04-28 |
Family
ID=35431500
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK05754708T DK1761542T3 (da) | 2004-06-09 | 2005-06-01 | Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidler |
Country Status (21)
Country | Link |
---|---|
US (2) | US7164019B2 (es) |
EP (1) | EP1761542B1 (es) |
JP (1) | JP2008501743A (es) |
CN (1) | CN101001860A (es) |
AR (1) | AR049209A1 (es) |
AT (1) | ATE382623T1 (es) |
AU (1) | AU2005251891A1 (es) |
BR (1) | BRPI0511982A (es) |
CA (1) | CA2569910A1 (es) |
DE (1) | DE602005004144T2 (es) |
DK (1) | DK1761542T3 (es) |
ES (1) | ES2297727T3 (es) |
IL (1) | IL179534A0 (es) |
MX (1) | MXPA06014404A (es) |
NO (1) | NO20070137L (es) |
PL (1) | PL1761542T3 (es) |
PT (1) | PT1761542E (es) |
RU (1) | RU2006146608A (es) |
TW (1) | TW200701981A (es) |
WO (1) | WO2005121145A2 (es) |
ZA (1) | ZA200609837B (es) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007045573A1 (en) | 2005-10-19 | 2007-04-26 | F. Hoffmann-La Roche Ag | Phenyl-acetamide nnrt inhibitors |
WO2007093520A1 (en) * | 2006-02-15 | 2007-08-23 | F. Hoffmann-La Roche Ag | Hetero-bycyclic antiviral compounds |
RU2008136763A (ru) * | 2006-02-15 | 2010-03-20 | Ф.Хоффманн-Ля Рош Аг (Ch) | Гетероциклические противовирусные соединения |
AU2007286345B2 (en) | 2006-08-16 | 2012-03-08 | F. Hoffmann-La Roche Ag | Non-nucleoside reverse transcriptase inhibitors |
US20080108586A1 (en) * | 2006-09-06 | 2008-05-08 | Incyte Corporation | Combination therapy for human immunodeficiency virus infection |
EP2066674B1 (en) * | 2006-09-18 | 2010-06-30 | F.Hoffmann-La Roche Ag | Octahydropyrrolo [3, 4-c] pyrrole derivatives and their use as antiviral agents |
TWI404532B (zh) * | 2006-11-02 | 2013-08-11 | Targacept Inc | 菸鹼乙醯膽鹼受體亞型選擇性之二氮雜雙環烷類醯胺 |
AU2007332654B2 (en) | 2006-12-13 | 2013-06-20 | F. Hoffmann-La Roche Ag | 2-(piperidin-4-yl)-4-phenoxy- or phenylamino-pyrimidine derivatives as non-nucleoside reverse transcriptase inhibitors |
US8464207B2 (en) * | 2007-10-12 | 2013-06-11 | Novell Intellectual Property Holdings, Inc. | System and method for tracking software changes |
GB0724251D0 (en) | 2007-12-12 | 2008-02-06 | Univ Edinburgh | Therapeutic compounds and their use |
GB0804685D0 (en) | 2008-03-13 | 2008-04-16 | Univ Edinburgh | Therapeutic compounds and their use |
US8642621B2 (en) | 2009-09-16 | 2014-02-04 | The University Of Edinburgh | (4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use |
MX2012007935A (es) | 2010-01-07 | 2012-08-15 | Du Pont | Compuestos heterociclicos fungicidas. |
BR112012027640B1 (pt) | 2010-04-29 | 2021-08-03 | The University Of Edinburgh | Composto, composição farmacêutica, e, métodos de preparar uma composição farmacêutica, de inibir a função da 11beta-hidroxiesteroide desidrogenase do tipo 1 |
DE102010025663A1 (de) * | 2010-06-30 | 2012-01-05 | Karl-Heinz Glüsenkamp | Neue beta-Aminoaldehyd-Derivate, Verfahren zu ihrer Herstellung und ihre chemische Verwendung als reaktive Intermediate |
SI2861566T1 (sl) | 2012-06-13 | 2017-03-31 | F. Hoffmann-La Roche Ag | Novi diazaspirocikloalkan in azaspirocikloalkan |
LT2900669T (lt) * | 2012-09-25 | 2019-11-11 | Hoffmann La Roche | Heksahidropirol[3,4-c]pirolo dariniai ir susiję junginai kaip autotaksino (atx) inhibitoriai ir kaip lizofosfatidinės rūgšties (lpa) gamybos inhibitoriai, skirti gydyti pvz., inkstų ligas |
AR095079A1 (es) | 2013-03-12 | 2015-09-16 | Hoffmann La Roche | Derivados de octahidro-pirrolo[3,4-c]-pirrol y piridina-fenilo |
ES2707739T3 (es) | 2013-09-26 | 2019-04-04 | Cadent Therapeutics Inc | Moduladores negativos de octahidro-ciclopenta[c]pirrol selectivo de NR2B |
DK3074400T3 (en) | 2013-11-26 | 2018-01-15 | Hoffmann La Roche | Octahydro-cyclobuta [1,2-c; 3,4-c '] dipyrrole derivatives as autotaxin inhibitors |
CN104744451A (zh) * | 2013-12-30 | 2015-07-01 | 中国科学院上海药物研究所 | 一种1-(3-氨基丙基)取代环状胺类化合物、其制备方法、药物组合物及用途 |
MX370659B (es) | 2014-03-26 | 2019-12-19 | Hoffmann La Roche | Compuestos bicíclicos como inhibidores de producción de autotaxina (atx) y ácido lisofosfatídico (lpa). |
CN106029667B (zh) | 2014-03-26 | 2019-08-23 | 豪夫迈·罗氏有限公司 | 作为自分泌运动因子(atx)和溶血磷脂酸(lpa)生产抑制剂的稠合[1,4]二氮杂*化合物 |
JO3579B1 (ar) * | 2014-09-26 | 2020-07-05 | Luc Therapeutics Inc | مُعدِلات تفاغرية سالبة لمستقبل nr2b من المركب n-ألكيل أريل-5-أوكسي أريل-ثامن هيدرو-خماسي الحلقة [c] بيرول |
MA41898A (fr) | 2015-04-10 | 2018-02-13 | Hoffmann La Roche | Dérivés de quinazolinone bicyclique |
PE20180479A1 (es) | 2015-09-04 | 2018-03-07 | Hoffmann La Roche | Nuevos derivados de fenoximetilo |
RU2018112230A (ru) | 2015-09-24 | 2019-10-30 | Ф. Хоффманн-Ля Рош Аг | Бициклические соединения в качестве ингибиторов atx |
MX2017015034A (es) | 2015-09-24 | 2018-04-13 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de autotaxina (atx)/anhidrasa carbonica (ca). |
CR20180057A (es) | 2015-09-24 | 2018-04-02 | Hoffmann La Roche | Nuevos compuestos biciclicos como inhibidores duales de atx/ca. |
MA42918A (fr) | 2015-09-24 | 2018-08-01 | Hoffmann La Roche | Composés bicycliques utilisés en tant qu'inhibiteurs d'atx |
WO2018011681A1 (en) | 2016-07-14 | 2018-01-18 | Pfizer Inc. | Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme |
SG11201908560SA (en) | 2017-03-16 | 2019-10-30 | Hoffmann La Roche | Heterocyclic compounds useful as dual atx/ca inhibitors |
CN110382484B (zh) | 2017-03-16 | 2022-12-06 | 豪夫迈·罗氏有限公司 | 新的作为atx抑制剂的二环化合物 |
US11629196B2 (en) | 2020-04-27 | 2023-04-18 | Incelldx, Inc. | Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions |
CN115698010A (zh) * | 2020-06-10 | 2023-02-03 | 赛克松公司 | 用于制备结晶形式的rabeximod的方法 |
CN113845439B (zh) * | 2021-10-11 | 2024-02-09 | 杭州师范大学 | 双苄酰胺类cxcr4拮抗剂及其制备和应用 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3930266A1 (de) | 1989-09-11 | 1991-03-14 | Thomae Gmbh Dr K | Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
DE4338396A1 (de) | 1993-11-10 | 1995-05-11 | Basf Ag | N-Substituierte Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
DE4341403A1 (de) | 1993-12-04 | 1995-06-08 | Basf Ag | N-substituierte 3-Azabicycloalkan-Derivate, ihre Herstellung und Verwendung |
US5457121A (en) | 1994-09-02 | 1995-10-10 | Eli Lilly And Company | Cis-hexahydro-5-(1,2,3,4-tetrahydro-2-naphthalenyl)pyrrolo<3,4-c>pyrroles as inhibitors of serotonin reuptake |
EP0728758B1 (de) * | 1995-02-27 | 2003-10-15 | F. Hoffmann-La Roche Ag | Dioxopyrrolo-pyrrolderivate |
GB9519563D0 (en) | 1995-09-26 | 1995-11-29 | Merck Sharp & Dohme | Therapeutic agents |
SK17899A3 (en) | 1996-08-13 | 2000-02-14 | Merck & Co Inc | Palladium catalyzed indolization |
PE20001420A1 (es) | 1998-12-23 | 2000-12-18 | Pfizer | Moduladores de ccr5 |
US7217714B1 (en) | 1998-12-23 | 2007-05-15 | Agouron Pharmaceuticals, Inc. | CCR5 modulators |
AU3555200A (en) * | 1999-03-17 | 2000-10-04 | F. Hoffmann-La Roche Ag | Oxazolone derivatives and their use as alpha-1 adrenoreceptor modulators |
HUP0203528A3 (en) | 1999-05-04 | 2003-11-28 | Schering Corp | Piperidine derivatives useful as ccr5 antagonists, pharmaceutical compositions containing them and their use |
BR0010304A (pt) | 1999-05-04 | 2002-02-13 | Schering Corp | Derivados de piperazina úteis como antagonistas do ccr5 |
DE60016454T2 (de) | 1999-12-03 | 2005-08-04 | Ono Pharmaceutical Co. Ltd. | Triazaspiro[5.5]undecanderivate und Drogen, die dasselbe als aktiven Inhaltsstoff enthalten |
US6815438B2 (en) | 1999-12-14 | 2004-11-09 | Neurosearch A/S | Heteroaryl-diazabicycloalkanes |
ES2249237T3 (es) | 2000-01-05 | 2006-04-01 | Pfizer Inc. | Compuestos de bencimidazol como antagonistas del receptor orl1. |
DE60135685D1 (de) | 2000-05-26 | 2008-10-16 | Pfizer | Triazolyltropanderivate als ccr5-modulatoren |
EP1304926B1 (en) | 2000-07-21 | 2005-12-21 | AK Food Technology, Inc | Liquid infusion and tenderization process, apparatus, and product |
SE0100326D0 (sv) * | 2001-02-02 | 2001-02-02 | Astrazeneca Ab | New compounds |
BR0207952A (pt) * | 2001-03-07 | 2004-07-27 | Pfizer Prod Inc | Moduladores da atividade de receptores de quimiocina |
GB0211418D0 (en) * | 2002-05-17 | 2002-06-26 | Glaxo Group Ltd | Compounds |
AR042628A1 (es) | 2002-12-20 | 2005-06-29 | Astrazeneca Ab | Derivados de piperidina como moduladores del receptor ccr5 |
-
2005
- 2005-06-01 ES ES05754708T patent/ES2297727T3/es active Active
- 2005-06-01 CN CNA2005800270118A patent/CN101001860A/zh active Pending
- 2005-06-01 JP JP2007526249A patent/JP2008501743A/ja active Pending
- 2005-06-01 PL PL05754708T patent/PL1761542T3/pl unknown
- 2005-06-01 AT AT05754708T patent/ATE382623T1/de not_active IP Right Cessation
- 2005-06-01 CA CA002569910A patent/CA2569910A1/en not_active Abandoned
- 2005-06-01 DK DK05754708T patent/DK1761542T3/da active
- 2005-06-01 EP EP05754708A patent/EP1761542B1/en active Active
- 2005-06-01 DE DE602005004144T patent/DE602005004144T2/de active Active
- 2005-06-01 WO PCT/EP2005/005895 patent/WO2005121145A2/en active IP Right Grant
- 2005-06-01 AU AU2005251891A patent/AU2005251891A1/en not_active Abandoned
- 2005-06-01 RU RU2006146608/04A patent/RU2006146608A/ru not_active Application Discontinuation
- 2005-06-01 BR BRPI0511982-0A patent/BRPI0511982A/pt not_active IP Right Cessation
- 2005-06-01 PT PT05754708T patent/PT1761542E/pt unknown
- 2005-06-01 MX MXPA06014404A patent/MXPA06014404A/es active IP Right Grant
- 2005-06-08 AR ARP050102332A patent/AR049209A1/es unknown
- 2005-06-08 US US11/147,851 patent/US7164019B2/en not_active Expired - Fee Related
- 2005-07-08 TW TW094118518A patent/TW200701981A/zh unknown
-
2006
- 2006-11-23 IL IL179534A patent/IL179534A0/en unknown
- 2006-11-24 ZA ZA200609837A patent/ZA200609837B/xx unknown
- 2006-12-11 US US11/637,423 patent/US7714018B2/en not_active Expired - Fee Related
-
2007
- 2007-01-08 NO NO20070137A patent/NO20070137L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005121145A2 (en) | 2005-12-22 |
IL179534A0 (en) | 2007-05-15 |
US7714018B2 (en) | 2010-05-11 |
AR049209A1 (es) | 2006-07-05 |
PL1761542T3 (pl) | 2008-06-30 |
EP1761542B1 (en) | 2008-01-02 |
US7164019B2 (en) | 2007-01-16 |
ES2297727T3 (es) | 2008-05-01 |
PT1761542E (pt) | 2008-03-26 |
JP2008501743A (ja) | 2008-01-24 |
EP1761542A2 (en) | 2007-03-14 |
US20070117859A1 (en) | 2007-05-24 |
CN101001860A (zh) | 2007-07-18 |
DE602005004144D1 (de) | 2008-02-14 |
RU2006146608A (ru) | 2008-07-20 |
CA2569910A1 (en) | 2005-12-22 |
US20060014767A1 (en) | 2006-01-19 |
BRPI0511982A (pt) | 2008-01-22 |
ZA200609837B (en) | 2008-09-25 |
MXPA06014404A (es) | 2007-02-19 |
NO20070137L (no) | 2007-03-06 |
TW200701981A (en) | 2007-01-16 |
AU2005251891A1 (en) | 2005-12-22 |
DE602005004144T2 (de) | 2009-01-29 |
ATE382623T1 (de) | 2008-01-15 |
WO2005121145A3 (en) | 2006-03-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1761542T3 (da) | Octahydropyrrolo[3,4-C] pyrrolderivater og anvendelsen deraf som antivirusmidler | |
NO20054330D0 (no) | 8-substituerte-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater | |
NO20053955D0 (no) | Pyrazolo [1,5-A] pyrimidinderivater | |
NO20054331D0 (no) | Substituerte-8-perfluoralkyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on-derivater | |
DK1966202T3 (da) | Heteroarylsubstituerede pyrrolo[2,3-b]pyridiner og pyrrolo[2,3-d]pyrimidiner som Januskinaseinhibitorer | |
IS8403A (is) | Pýrrólafleiður með bakteríueyðandi virkni | |
EP2223921B8 (en) | 2-Thiophen-2-yl-oxazole, 2-Thiophen-2-yl-thiazole and 2-Thiophen-2-yl-1H-imidazole derivatives as antiviral agents | |
HK1103730A1 (en) | Pyrrolopyridine derivatives and their use as crth2antagonists | |
IS8575A (is) | 3-ß-D-ríbófúranósýlþíasóló [4,5-d]pýridímínnúkleósíð og notkun þeirra | |
HUE041596T2 (hu) | Pirrol származékok mint gyógyászati szerek | |
IS7872A (is) | Pýrrólópýrimidín afleiður | |
ATE384725T1 (de) | Pyrimido 4,5-d pyrimidinderivate mitantikrebswirkung | |
NO20054905D0 (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
IS2795B (is) | Pýrasóló[3,4-b]pýridín efnasambönd, og notkun þeirra sem fosfórdíesterasa hindrar | |
IL182610A0 (en) | Tetracyclic indole derivatives as antiviral agents | |
ATE360632T1 (de) | Substituierte 8'-pyri(mi)dinyl-dihydrospiro- (cycloalkylamin)-pyrimido(1,2a)pyrimidin-6- onderivate | |
IL174512A0 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
DK1814880T3 (da) | Imidazo[1,2-a]pyridinforbindelser, og sammensætninger, anvendelser og fremgangsmåder, der er forbundet dermed | |
NL1030503A1 (nl) | Octahydropyrrolo[3,4-c]-pyrroolderivaten. | |
IL198239A0 (en) | Substituted 8-piperidinyl-2-pyridinyl-pyrimido [1,2-a] pyrimidin -6- one and 8-piperidinyl-2- pyrimidinyl [1,2-a] pyrimidin -6- one derivatives | |
DK1902054T3 (da) | Pyrido[2,3-d]pyrimidinderivater, fremstilling og terapeutisk anvendelse heraf | |
DK1315731T3 (da) | 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on og 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1H)on-derivater | |
DK1534707T3 (da) | Substituerede 2,4-dihydropyrrolo[3,4-b]quinolin-9-on-derivater egnede som phosphodiesteraseinhibitorer | |
NL1024677A1 (nl) | Therapeutische prolinederivaten. | |
DK1560830T3 (da) | Derivater af [6,7-dihydro-5H-imidazo[1,2-A]imidazol-3-sulfonylamino]propionamid og anvendelse deraf som inhibitorer af interaktionen mellem CAM'er og leukointegriner |